<span item_type="fundamental" item_id="5a23fd61002e23de938f9d962c3f5949" counter_id="ST/US/CUBWW" env="prod"></span><span item_type="announcement" item_id="515625488873619585" env="prod"></span><p>EPS: As of FY2025 Q1, the actual value is USD 0.07.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Trust Account</strong>: As of March 31, 2025, the Trust Account held $238,782,364, compared to $236,335,105 as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015955/000121390025042278/ea0240972-10q_lionheart.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Income</strong>: For the three months ended March 31, 2025, net income was $2,198,698, compared to a net loss of $22,260 for the period from February 21, 2024 (inception) through March 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015955/000121390025042278/ea0240972-10q_lionheart.htm"></span></li><li><strong>General and Administrative Costs</strong>: For the three months ended March 31, 2025, general and administrative and formation costs were $248,561, compared to $22,260 for the period from February 21, 2024 (inception) through March 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015955/000121390025042278/ea0240972-10q_lionheart.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: For the three months ended March 31, 2025, cash used in operating activities was - $193,339, compared to - $21,943 for the period from February 21, 2024 (inception) through March 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015955/000121390025042278/ea0240972-10q_lionheart.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Dividend Income</strong>: Dividend earned on marketable securities held in the Trust Account was $2,447,259 for the three months ended March 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015955/000121390025042278/ea0240972-10q_lionheart.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company plans to use the funds held in the Trust Account to complete a Business Combination, with the possibility of issuing additional securities or incurring debt if necessary.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015955/000121390025042278/ea0240972-10q_lionheart.htm"></span></li><li><strong>Non-Core Business</strong>: The company may seek to extend the Combination Period by amending its Amended and Restated Articles, which would require shareholder approval and could affect its Nasdaq listing.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015955/000121390025042278/ea0240972-10q_lionheart.htm"></span></li></ul>

LIONHEART HLDGS C/WTS 07/06/2031(TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD 0.07